|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Industry in China
Aruvian's R'search, March 2009, Pages: 80
Favorable economic conditions are expected to continue to boost the growth of the pharmaceutical industry in China. The health of the pharmaceutical industry has been improving continuously since 2000 and is expected to get even better.
The Chinese pharmaceuticals market is forecast to become the worlds firth largest by 2010 - and the largest by 2050. There are still greater market access following Chinas entry into the World Trade Organization (WTO), multinational investors continue to face a range of obstacles, many of which stem from the legacy of central planning of the industry. These include complex distribution, under-developed retail options, intellectual property infringements and pricing controls and pressures. At the same time, the continuing reliance of leading domestic companies on generic drugs has prevented the emergence of Chinese brands.
However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house.
This report Pharmaceutical Industry in China explores the Chinese Pharmaceutical Industry landscape from the basics to the issues facing the industry today. The report delves in to the WTO accession of China and the impact it has had on the Chinese Pharmaceutical Industry, growth trends in the industry, competition in the industry, etc.
The report also analyzes the Chinese pharmaceutical industry through three frameworks - a SWOT analysis, a PEST analysis, and a Porter’s Five Forces Business Strategy analysis. The report also looks at strategies for market entry, the role of R&D in the Chinese Pharmaceutical Industry, the role of the government in the industry, and investment opportunities in China’s Pharmaceutical Industry.
Complete with a comprehensive section on the clinical trials, market investment opportunities, an analysis of the fifteen leading players in the Chinese Pharmaceutical Industry, Aruvian’s latest research is a collection of all you need to know about China’s Pharmaceutical Industry.
Customers who bought this item also bought
China Pharmaceutical Industry: Analysis and Market Trends
In-Depth Analysis of the China Pharmaceutical Market
Canada Pharmaceutical Industry
Chinese Pharmaceutical Industry
China Pharmaceutical Logistics Industry Report, 2008
China Pharmaceutical Logistics Industry Report, 2008
China Pharmaceutical Chain Industry Report, 2007-2008
China Pharmaceutical Chain Industry Report, 2007-2008
China Pharmaceutical Logistics Industry Report, 2009
China Pharmaceutical Logistics Industry Report, 2009
China Pharmaceutical Chain Industry Report, 2009
China Pharmaceutical Chain Industry Report, 2009
|
|
|
|
